Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-024380

IDERA PHARMACEUTICALS, INC. · IDRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Youssef El Zein
Director · 10% Owner
Pillar Invest Corp
Director · 10% Owner
Pillar Pharmaceuticals II, L.P.
Director · 10% Owner
Period of report
Oct 16, 2017
Accepted (ET)
Oct 17, 2017 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F1Oct 16, 2017X6,842,844$0.00A0ISee Footnotes

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
WarrantsF1,F2$0.70Oct 16, 2017X6,842,844DNov 9, 2012Nov 9, 2017Common Stock6,842,8440I

Explanation of responses